|
業務類別
|
Medical Devices |
|
業務概覽
|
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use. |
| 公司地址
| 9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850 |
| 電話號碼
| +1 301 944-1700 |
| 傳真號碼
| +1 301 944-1703 |
| 公司網頁
| https://www.maxcyte.com |
| 員工數量
| 91 |
| Mr. Maher Masoud |
President, Chief Executive Officer and Director |
美元 590.00K |
29/04/2026 |
| Mr. Parmeet Ahuja |
Chief Financial Officer and Principal Accounting Officer |
-- |
27/03/2026 |
|
|
| Ms. Cynthia Lynne Collins |
Independent Director |
29/04/2026 |
| Mr. Stanley Charles Erck |
Independent Director |
29/04/2026 |
| Mr. Patrick J Balthrop Sr |
Independent Director |
29/04/2026 |
| Dr. Richard H. Douglas, PhD |
Non-Executive Chairman of the Board |
29/04/2026 |
| Mr. John Joseph Johnston |
Independent Director |
29/04/2026 |
| Dr. Yasir B. Al-Wakeel, B.M. |
Independent Director |
29/04/2026 |
| Mr. William Wade Brooke |
Independent Director |
29/04/2026 |
| Ms. Rekha Hemrajani, M.B.A. |
Independent Director |
29/04/2026 |
| Mr. Maher Masoud |
President, Chief Executive Officer and Director |
29/04/2026 |
|
|
|
|
